Literature DB >> 25374490

Risk Factors for Delayed Recurrence of Clostridium difficile Infection.

Ji Won Kim1.   

Abstract

Entities:  

Year:  2014        PMID: 25374490      PMCID: PMC4214951          DOI: 10.5217/ir.2014.12.4.266

Source DB:  PubMed          Journal:  Intest Res        ISSN: 1598-9100


× No keyword cloud information.
Clostridium difficile (C. difficile) is an anaerobic, gram-positive, spore-forming bacterium, and C. difficile infection (CDI) is a common cause of infectious diarrhea and pseudomembranous colitis. The incidence of CDI is increasing worldwide, most likely as a result of the increased use of antibiotics, and the subsequent emergence of hypervirulent strains.1 In Western countries, the incidence and severity of CDI are also increasing.2 Furthermore, recent reports suggest that in Asian countries, C. difficile is more prevalent than previously thought, and that the incidence of CDI is also increasing significantly in Korea.3,4 Recurrent CDI occurs either due to relapse (persistence of the same strain of C. difficile) or reinfection (acquisition of a new strain of C. difficile). The impact of recurrent CDI is significant because it influences the length of hospitalization and the cost of treatment.5 In a Canadian study of hospitalized patients, the independent predictors of recurrent CDI were found to be old age, acquisition of CDI during a hospital stay, and length of hospital stay.6 In a recent meta-analysis conducted by Garey et al., continued use of antibiotics after diagnosis, concomitant antacid medication, and old age were significant predictors of recurrent CDI.7 The risk factors associated with recurrent CDI have been investigated in some studies conducted in Korea.8,9,10 In a study by Kim et al., of 125 patients that developed C. difficile-associated diarrhea, 27 patients (21.6%) experienced one or more recurrence, and the risk factors for the CDI recurrence were identified as advanced age (over 65 years), a serum albumin level below 2.5 g/dL, and concurrent use of proton pump inhibitors.8 Jung et al. suggested that a history of surgery is a predictor of recurrence after metronidazole treatment of CDI.9 In a study by Ryu et al., patients who received tube feeding were at an increased risk of recurrent CDI.10 However, in these studies, the recurrence of CDI was evaluated only between weeks and 90 days only. In the present study,11 the authors investigated the long-term clinical outcomes of CDI in hospitalized patients in a single center. The authors evaluated delayed CDI recurrence after eight weeks of successful treatment response. The predictive factors associated with delayed CDI recurrence were tube feeding, and the use of anti-gastric acid medications. Tube feeding is a known risk factor for CDI because it can act as a transmission factor for C. difficile. Aseptic control of the feeding tube may aid in reducing contamination, and therefore preventing CDI. Another important result of this study is the mortality rate of patients with CDI. Although no deaths were attributed to CDI, the results of this study suggest that CDI may predict the poor prognosis of underlying diseases. As the authors mentioned, this study was limited in that it was retrospective, performed in a single center, and the hypervirulent strain was not evaluated appropriately. Another weak point of this study is that antacid medication history was not clearly defined. It would have been better if the authors had clarified the temporal relationship between antacid exposure and the development of diarrheal symptoms. In conclusion, risk factors for delayed recurrence of CDI were identified in the present paper. This study suggests that more sanitary manipulation of feeding tubes may prevent the recurrence of CDI. Further prospective studies with a large number of patients are needed to more accurately elucidate the factors associated with recurrent CDI.
  10 in total

1.  An epidemic, toxin gene-variant strain of Clostridium difficile.

Authors:  L Clifford McDonald; George E Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

2.  Prevalence of Clostridium difficile toxin in diarhoeal stool samples of patients from a tertiary hospital in North Eastern Penisular Malaysia.

Authors:  Siti Asma' Hassan; Norlela Othman; Fauziah Mohd Idris; Zaidah Abdul Rahman; Nurahan Maning; Rosliza Abdul Rahman; Chan Guan Tiong
Journal:  Med J Malaysia       Date:  2012-08

3.  Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.

Authors:  Jacques Pepin; Marie-Eve Alary; Louis Valiquette; Evelyne Raiche; Joannie Ruel; Katalin Fulop; Dominique Godin; Claude Bourassa
Journal:  Clin Infect Dis       Date:  2005-04-25       Impact factor: 9.079

4.  Risk Factors for Treatment Failure and Recurrence after Metronidazole Treatment for Clostridium difficile-associated Diarrhea.

Authors:  Kyu Sik Jung; Jae Jun Park; Young Eun Chon; Eun Suk Jung; Hyun Jung Lee; Hui Won Jang; Kyong Joo Lee; Sang Hoon Lee; Chang Mo Moon; Jin Ha Lee; Jae Kook Shin; Soung Min Jeon; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

5.  Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.

Authors:  Ji Won Kim; Kook Lae Lee; Ji Bong Jeong; Byeong Gwan Kim; Sue Shin; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

6.  Meta-analysis to assess risk factors for recurrent Clostridium difficile infection.

Authors:  K W Garey; S Sethi; Y Yadav; H L DuPont
Journal:  J Hosp Infect       Date:  2008-10-31       Impact factor: 3.926

Review 7.  Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.

Authors:  Stuart Johnson
Journal:  J Infect       Date:  2009-04-05       Impact factor: 6.072

8.  Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

Authors:  Rocco Ricciardi; David A Rothenberger; Robert D Madoff; Nancy N Baxter
Journal:  Arch Surg       Date:  2007-07

9.  Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study.

Authors:  Y S Kim; D S Han; Y H Kim; W H Kim; J S Kim; H S Kim; H S Kim; Y S Park; H J Song; S J Shin; S K Yang; B D Ye; C S Eun; K M Lee; S H Lee; B I Jang; S A Jung; J H Cheon; C H Choi; K C Huh
Journal:  Epidemiol Infect       Date:  2012-04-12       Impact factor: 4.434

10.  Long-Term Clinical Outcome of Clostridium difficile Infection in Hospitalized Patients: A Single Center Study.

Authors:  Young Seok Doh; You Sun Kim; Hye Jin Jung; Young Il Park; Jin Won Mo; Hyun Sung; Kyung Jin Lee; Young Ki Seo; Jeong Seop Moon; Seong Woo Hong
Journal:  Intest Res       Date:  2014-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.